clinical trial
-
healthDMT Shows Dramatic Depression Symptom Reduction in New Trial
A single dose of the psychedelic DMT significantly reduced major depressive disorder symptoms in a recent Phase IIa trial, offering hope for rapid-acting treatments.
-
healthBimekizumab Shows 3-Year Psoriasis Symptom and Quality of Life Improvements
Three-year data from the BE RADIANT trial confirm bimekizumab's sustained effectiveness in treating moderate-to-severe plaque psoriasis, significantly improving patient-reported symptoms and quality of life.
-
healthSingle Vaccine Targets Flu and COVID-19, Shows Promising Results
New multicomponent mRNA vaccine demonstrates safety and robust immune response against influenza and COVID-19 in early trials.
-
healthElenagen Extends Survival in Platinum-Resistant Ovarian Cancer
New Phase II data shows Elenagen combined with gemcitabine significantly improves overall survival for ovarian cancer patients, without added toxicity.
-
healthApple Watch Revolutionizes Atrial Fibrillation Detection in High-Risk Seniors
A new study reveals smartwatches significantly improve early detection of atrial fibrillation, a key stroke risk factor, in older adults.
-
healthPsychedelic Compound Shows Promise in Cutting Depression Symptoms
A clinical study reveals that a single dose of DMT, a naturally occurring psychedelic, significantly reduced depression symptoms in participants.
-
healthTiming is Key: Early Immunochemotherapy Dramatically Boosts Lung Cancer Survival
New trial data reveals that delivering immunochemotherapy earlier in advanced non-small cell lung cancer patients significantly improves progression-free and overall survival.
-
healthDMT Shows Antidepressant Promise in Small Clinical Trial
A small clinical trial suggests the hallucinogen DMT may be an effective antidepressant, offering hope for new treatment options.